Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tracy T Batchelor
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
105 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Kirklin Clinic at Acton Road
Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Arizona Oncology Services Foundation
Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Saint Joseph Hospital - Orange
Orange, California, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Bay Medical Center
Panama City, Florida, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
- the Cancer Center of Hawaii-Liliha
Honolulu, Hawaii, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Osf Saint Francis Medical Center
Peoria, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- Parkview Hospital Randallia
Fort Wayne, Indiana, United States
- Radiation Oncology Associates Pc
Fort Wayne, Indiana, United States
- Iu Health Methodist Hospital
Indianapolis, Indiana, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- Kansas City Nci Community Oncology Research Program
Prairie Village, Kansas, United States
- Baptist Health Lexington
Lexington, Kentucky, United States
- University of Kentucky/markey Cancer Center
Lexington, Kentucky, United States
- Maine Medical Center- Scarborough Campus
Scarborough, Maine, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Henry Ford Macomb Hospital-Clinton Township
Clinton Township, Michigan, United States
- Ascension Saint John Hospital
Detroit, Michigan, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Genesys Regional Medical Center-West Flint Campus
Flint, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Feb 2010
- Primary completion
- 6 Dec 2015
- Completion
- 20 May 2022
- Last update posted
- 26 Jul 2022
- Registered enrollment
- 261
- Registry id
- NCT01062425
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.